Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Arnold

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2008
Unsuspected, disseminated coccidioidomycosis without maternofetal morbidity diagnosed by placental examination: case report and review of the literatureChristina A Arnold, Dinesh Rakheja, Michael A Arnold, et al.
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Blood|July 9, 2009
Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2CMaike Schwieger, Andrea Schüler, Martin Forster, et al.
The American Journal of Surgical Pathology|December 24, 2016
Crospovidone and Microcrystalline Cellulose: A Novel Description of Pharmaceutical Fillers in the Gastrointestinal TractSophia M Shaddy, Michael A Arnold, Konstantin Shilo, et al.
Pediatric Blood & Cancer|March 20, 2025
Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology GroupJamie M Aye, Wei Xue, Zhengya Gao, et al.
Developmental Cell|March 6, 2007
MEF2C transcription factor controls chondrocyte hypertrophy and bone developmentMichael A Arnold, Yuri Kim, Michael P Czubryt, et al.
Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
American Journal of Clinical Pathology|February 4, 2017
Challenges to "Classic" Esophageal Candidiasis: Looks Are Usually DeceivingMohammed I Alsomali, Michael A Arnold, Wendy L Frankel, et al.
Molecular and Cellular Biology|March 16, 2006
PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cellsChristopher A Davis, Michael Haberland, Michael A Arnold, et al.
International Journal of Cancer|October 18, 2019
GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcomaManish Charan, Piyush Dravid, Maren Cam, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2008
Unsuspected, disseminated coccidioidomycosis without maternofetal morbidity diagnosed by placental examination: case report and review of the literatureChristina A Arnold, Dinesh Rakheja, Michael A Arnold, et al.
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Blood|July 9, 2009
Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2CMaike Schwieger, Andrea Schüler, Martin Forster, et al.
The American Journal of Surgical Pathology|December 24, 2016
Crospovidone and Microcrystalline Cellulose: A Novel Description of Pharmaceutical Fillers in the Gastrointestinal TractSophia M Shaddy, Michael A Arnold, Konstantin Shilo, et al.
Pediatric Blood & Cancer|March 20, 2025
Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology GroupJamie M Aye, Wei Xue, Zhengya Gao, et al.
Developmental Cell|March 6, 2007
MEF2C transcription factor controls chondrocyte hypertrophy and bone developmentMichael A Arnold, Yuri Kim, Michael P Czubryt, et al.
Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
American Journal of Clinical Pathology|February 4, 2017
Challenges to "Classic" Esophageal Candidiasis: Looks Are Usually DeceivingMohammed I Alsomali, Michael A Arnold, Wendy L Frankel, et al.
Molecular and Cellular Biology|March 16, 2006
PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cellsChristopher A Davis, Michael Haberland, Michael A Arnold, et al.
International Journal of Cancer|October 18, 2019
GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcomaManish Charan, Piyush Dravid, Maren Cam, et al.
Pageof 10